These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2086756)

  • 1. [Benzisoselenazolinones and their derivatives, a new series of anti-inflammatories and antioxidants].
    Renson M; Dereu N
    J Pharm Belg; 1990; 45(5):322-30. PubMed ID: 2086756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates.
    Sarma BK; Mugesh G
    Chemistry; 2008; 14(34):10603-14. PubMed ID: 18932179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and antioxidant activity of some ebselen analogues.
    Bhabak KP; Mugesh G
    Chemistry; 2007; 13(16):4594-601. PubMed ID: 17299817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
    Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
    Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.
    Mishra B; Priyadarsini KI; Mohan H; Mugesh G
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen: a new approach to the inhibition of peroxide-dependent inflammation.
    Parnham MJ; Leyck S; Kuhl P; Schalkwijk J; van den Berg WB
    Int J Tissue React; 1987; 9(1):45-50. PubMed ID: 3036734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reaction of ebselen with peroxynitrite.
    Masumoto H; Sies H
    Chem Res Toxicol; 1996; 9(1):262-7. PubMed ID: 8924601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of seleno-organic compounds on leukotriene B4 biosynthesis].
    Liu DP; Cheng GF; Bai JY; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1993; 28(6):472-6. PubMed ID: 8249607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase/5-lipoxygenase pathways and anti-inflammatory activity.
    Galet V; Bernier JL; Hénichart JP; Lesieur D; Abadie C; Rochette L; Lindenbaum A; Chalas J; Renaud de la Faverie JF; Pfeiffer B
    J Med Chem; 1994 Sep; 37(18):2903-11. PubMed ID: 8071938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of ebselen.
    Parnham MJ; Leyck S; Graf E; Dowling EJ; Blake DR
    Agents Actions; 1991 Jan; 32(1-2):4-9. PubMed ID: 2058468
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological activities and clinical potential of Ebselen.
    Parnham MJ
    Adv Exp Med Biol; 1990; 264():193-7. PubMed ID: 2244495
    [No Abstract]   [Full Text] [Related]  

  • 12. Selenium compounds counteract the stimulation of ecto-nucleotidase activities in rat cultured cerebellar granule cells: putative correlation with neuroprotective effects.
    Ghisleni G; Porciúncula LO; Mioranzza S; Boeck CR; Rocha JB; Souza DO
    Brain Res; 2008 Jul; 1221():134-40. PubMed ID: 18554575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen, a selenium-containing redox drug, releases zinc from metallothionein.
    Jacob C; Maret W; Vallee BL
    Biochem Biophys Res Commun; 1998 Jul; 248(3):569-73. PubMed ID: 9703967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of substituents on the GPx-like activity of ebselen: steric versus electronic.
    Pearson JK; Boyd RJ
    J Phys Chem A; 2008 Feb; 112(5):1013-7. PubMed ID: 18197644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs).
    Parnham MJ; Biedermann J; Bittner C; Dereu N; Leyck S; Wetzig H
    Agents Actions; 1989 Jun; 27(3-4):306-8. PubMed ID: 2801314
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds.
    Nogueira CW; Rocha JB
    Arch Toxicol; 2011 Nov; 85(11):1313-59. PubMed ID: 21720966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant and anti-mutagenic effects of ebselen in yeast and in cultured mammalian V79 cells.
    Miorelli ST; Rosa RM; Moura DJ; Rocha JC; Lobo LA; Henriques JA; Saffi J
    Mutagenesis; 2008 Mar; 23(2):93-9. PubMed ID: 18267951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions.
    Sarma BK; Mugesh G
    J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Selenization of salicylic acid derivatives yielded isoform-specific 5-lipoxygenase inhibitors.
    Yu SC; Kuhn H; Daniliuc CG; Ivanov I; Jones PG; du Mont WW
    Org Biomol Chem; 2010 Feb; 8(4):828-34. PubMed ID: 20135040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.